{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T22:20:59Z","timestamp":1794262859264,"version":"4.9.0"},"reference-count":199,"publisher":"Bentham Science Publishers Ltd.","issue":"36","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>The pathophysiology of major depressive disorder (MDD), one\nof the major causes of worldwide disability, is still largely unclear, despite the increasing\ndata reporting evidence of multiple alterations of different systems. Recently, there was a\nrenewed interest in the signalling of gamma aminobutyric acid (GABA) - the main inhibitory\nneurotransmitter.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>The aim of this study was to review and comment on the available literature\nabout the involvement of GABA in MDD, as well as on novel GABAergic compounds\npossibly useful as antidepressants.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>We carried out a narrative review through Pubmed, Google Scholar and Scopus,\nby using specific keywords.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The results, derived from various research tools, strongly support the presence\nof a deficiency of the GABA system in MDD, which appears to be restored by common\nantidepressant treatments. More recent publications would indicate the complex interactions\nbetween GABA and all the other processes involved in MDD, such as monoamine\nneurotransmission, hypothalamus-pituitary adrenal axis functioning, neurotrophism, and\nimmune response. Taken together, all these findings seem to further support the complexity\nof the pathophysiology of MDD, possibly reflecting the heterogeneity of the clinical\npictures.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Although further data are necessary to support the specificity of GABA deficiency\nin MDD, the available findings would suggest that novel GABAergic compounds\nmight constitute innovative therapeutic strategies in MDD.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929867328666211115124149","type":"journal-article","created":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T10:11:45Z","timestamp":1638180705000},"page":"5710-5730","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["GABA System in Depression: Impact on Pathophysiology and Psychopharmacology"],"prefix":"10.2174","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7905-9755","authenticated-orcid":true,"given":"Alessandra","family":"Della Vecchia","sequence":"first","affiliation":[{"name":"Department of Clinical and Experimental Medicine, Section of Psychiatry, University of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4398-6837","authenticated-orcid":true,"given":"Alessandro","family":"Arone","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, Section of Psychiatry, University of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2724-2830","authenticated-orcid":true,"given":"Armando","family":"Piccinni","sequence":"additional","affiliation":[{"name":"Saint Camillus International University of Health and Medical Sciences, Rome, Italy"},{"name":"Brain Research Foundation, Lucca, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9746-8237","authenticated-orcid":true,"given":"Federico","family":"Mucci","sequence":"additional","affiliation":[{"name":"Dipartimento di Biotecnologie, Chimica e Farmacia, University of Siena, Siena,\nItaly"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4021-5829","authenticated-orcid":true,"given":"Donatella","family":"Marazziti","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, Section of Psychiatry, University of Pisa, Pisa, Italy"},{"name":"Saint Camillus International University of Health and Medical Sciences, Rome, Italy"},{"name":"Brain Research Foundation, Lucca, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","unstructured":"Depression. World Health Organization (WHO)Available on: . (Accessed June 10, 2021)."},{"key":"ref=2","year":"2013","unstructured":"Diagnostic and Statistical Manual of Mental Disorders: DSM-5 American Psychiatric Association2013","journal-title":"Diagnostic and Statistical Manual of Mental Disorders: DSM-5"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1038\/nature07455","volume":"455","author":"Krishnan V.","year":"2008","unstructured":"Krishnan V.; Nestler E.J.; The molecular neurobiology of depression. Nature 2008,455(7215),894-902","journal-title":"Nature"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1176\/ajp.122.5.509","volume":"122","author":"Schildkraut J.J.","year":"1965","unstructured":"Schildkraut J.J.; The catecholamine hypothesis of affective disorders: A review of supporting evidence. Am J Psychiatry 1965,122(5),509-522","journal-title":"Am J Psychiatry"},{"key":"ref=5","first-page":"291","volume":"16","author":"van Praag H.M.","year":"1981","unstructured":"van Praag H.M.; Management of depression with serotonin precursors. Biol Psychiatry 1981,16(3),291-310","journal-title":"Biol Psychiatry"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1055\/s-2007-979535","volume":"29","author":"Heninger G.R.","year":"1996","unstructured":"Heninger G.R.; Delgado P.L.; Charney D.S.; The revised monoamine theory of depression: a modulatory role for monoamines, based on new findings from monoamine depletion experiments in humans. Pharmacopsychiatry 1996,29(1),2-11","journal-title":"Pharmacopsychiatry"},{"key":"ref=7","first-page":"336","volume":"1","author":"Nemeroff C.B.","year":"1996","unstructured":"Nemeroff C.B.; The corticotropin-releasing factor (CRF) hypothesis of depression: new findings and new directions. Mol Psychiatry 1996,1(4),336-342","journal-title":"Mol Psychiatry"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.biopsych.2006.02.013","volume":"59","author":"Duman R.S.","year":"2006","unstructured":"Duman R.S.; Monteggia L.M.; A neurotrophic model for stress-related mood disorders. Biol Psychiatry 2006,59(12),1116-1127","journal-title":"Biol Psychiatry"},{"key":"ref=9","first-page":"287","volume":"29","author":"Maes M.","year":"2008","unstructured":"Maes M.; The cytokine hypothesis of depression: inflammation, oxidative","journal-title":"Neuroendocrinol Lett"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.tins.2008.06.006","volume":"31","author":"Pariante C.M.","year":"2008","unstructured":"Pariante C.M.; Lightman S.L.; The HPA axis in major depression: classical theories and new developments. Trends Neurosci 2008,31(9),464-468","journal-title":"Trends Neurosci"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/164_2018_166","volume":"250","author":"Felger J.C.","year":"2019","unstructured":"Felger J.C.; Role of inflammation in depression and treatment implications. Handb Exp Pharmacol 2019,250,255-286","journal-title":"Handb Exp Pharmacol"},{"key":"ref=12","first-page":"385","volume":"21","author":"Bartholini G.","year":"1985","unstructured":"Bartholini G.; Lloyd K.G.; Scatton B.; Zivkovic B.; Morselli P.L.; The GABA hypothesis of depression and antidepressant drug action. Psychopharmacol Bull 1985,21(3),385-388","journal-title":"Psychopharmacol Bull"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/0278-5846(89)90123-1","volume":"13","author":"Lloyd K.G.","year":"1989","unstructured":"Lloyd K.G.; Zivkovic B.; Scatton B.; Morselli P.L.; Bartholini G.; The gabaergic hypothesis of depression. Prog Neuropsychopharmacol Biol Psychiatry 1989,13(3-4),341-351","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.biopsych.2016.09.017","volume":"81","author":"Tatti R.","year":"2017","unstructured":"Tatti R.; Haley M.S.; Swanson O.K.; Tselha T.; Maffei A.; Neurophysiology and regulation of the balance between excitation and inhibition in neocortical circuits. Biol Psychiatry 2017,81(10),821-831","journal-title":"Biol Psychiatry"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1176\/appi.ajp.160.8.1516","volume":"160","author":"Sheline Y.I.","year":"2003","unstructured":"Sheline Y.I.; Gado M.H.; Kraemer H.C.; Untreated depression and hippocampal volume loss. Am J Psychiatry 2003,160(8),1516-1518","journal-title":"Am J Psychiatry"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1001\/archpsyc.64.2.193","volume":"64","author":"Hasler G.","year":"2007","unstructured":"Hasler G.; van der Veen J.W.; Tumonis T.; Meyers N.; Shen J.; Drevets W.C.; Reduced prefrontal glutamate\/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy. Arch Gen Psychiatry 2007,64(2),193-200","journal-title":"Arch Gen Psychiatry"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"127","DOI":"10.2174\/187152707780363294","volume":"6","author":"Sanacora G.","year":"2007","unstructured":"Sanacora G.; Saricicek A.; GABAergic contributions to the pathophysiology of depression and the mechanism of antidepressant action. CNS Neurol Disord Drug Targets 2007,6(2),127-140","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/mp.2010.80","volume":"16","author":"MacQueen G.","year":"2011","unstructured":"MacQueen G.; Frodl T.; The hippocampus in major depression: Evidence for the convergence of the bench and bedside in psychiatric research? Mol Psychiatry 2011,16(3),252-264","journal-title":"Mol Psychiatry"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/bs.apha.2014.11.003","volume":"73","author":"Luscher B.","year":"2015","unstructured":"Luscher B.; Fuchs T.; GABAergic control of depression-related brain states. Adv Pharmacol 2015,73,97-144","journal-title":"Adv Pharmacol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.biopsych.2017.05.024","volume":"82","author":"Fee C.","year":"2017","unstructured":"Fee C.; Banasr M.; Sibille E.; Somatostatin-positive gamma-aminobutyric acid interneuron deficits in depression: Cortical microcircuit and therapeutic perspectives. Biol Psychiatry 2017,82(8),549-559","journal-title":"Biol Psychiatry"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.neuron.2019.03.013","volume":"102","author":"Duman R.S.","year":"2019","unstructured":"Duman R.S.; Sanacora G.; Krystal J.H.; Altered connectivity in depression: GABA and glutamate neurotransmitter deficits and reversal by novel treatments. Neuron 2019,102(1),75-90","journal-title":"Neuron"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3389\/fncel.2019.00087","volume":"13","author":"Foga\u00e7a M.V.","year":"2019","unstructured":"Foga\u00e7a M.V.; Duman R.S.; Cortical GABAergic dysfunction in stress and depression: new insights for therapeutic interventions. Front Cell Neurosci 2019,13,87","journal-title":"Front Cell Neurosci"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1038\/s41380-019-0426-0","volume":"24","author":"Sohal V.S.","year":"2019","unstructured":"Sohal V.S.; Rubenstein J.L.R.; Excitation-inhibition balance as a framework for investigating mechanisms in neuropsychiatric disorders. Mol Psychiatry 2019,24(9),1248-1257","journal-title":"Mol Psychiatry"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/0006-3223(92)90039-3","volume":"32","author":"Petty F.","year":"1992","unstructured":"Petty F.; Kramer G.L.; Gullion C.M.; Rush A.J.; Low plasma gamma-aminobutyric acid levels in male patients with depression. Biol Psychiatry 1992,32(4),354-363","journal-title":"Biol Psychiatry"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/0165-0327(95)00025-I","volume":"34","author":"Petty F.","year":"1995","unstructured":"Petty F.; GABA and mood disorders: a brief review and hypothesis. J Affect Disord 1995,34(4),275-281","journal-title":"J Affect Disord"},{"key":"ref=26","first-page":"1511","volume":"1","author":"Sharpley C.","year":"2009","unstructured":"Sharpley C.; Malfunction in GABA and glutamate as pathways to depression: a review of the evidence. Clin Med Insights Ther 2009,1,1511-1519","journal-title":"Clin Med Insights Ther"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/sj.npp.1301234","volume":"32","author":"Rajkowska G.","year":"2007","unstructured":"Rajkowska G.; O\u2019Dwyer G.; Teleki Z.; Stockmeier C.A.; Miguel-Hidalgo J.J.; GABAergic neurons immunoreactive for calcium binding proteins are reduced in the prefrontal cortex in major depression. Neuropsychopharmacology 2007,32(2),471-482","journal-title":"Neuropsychopharmacology"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/S0006-3223(01)01243-4","volume":"51","author":"Cotter D.","year":"2002","unstructured":"Cotter D.; Landau S.; Beasley C.; Stevenson R.; Chana G.; MacMillan L.; Everall I.; The density and spatial distribution of GABAergic neurons, labelled using calcium binding proteins, in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia. Biol Psychiatry 2002,51(5),377-386","journal-title":"Biol Psychiatry"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.biopsych.2010.04.024","volume":"68","author":"Shen Q.","year":"2010","unstructured":"Shen Q.; Lal R.; Luellen B.A.; Earnheart J.C.; Andrews A.M.; Luscher B.; gamma-Aminobutyric acid-type A receptor deficits cause hypothalamic-pituitary-adrenal axis hyperactivity and antidepressant drug sensitivity reminiscent of melancholic forms of depression. Biol Psychiatry 2010,68(6),512-520","journal-title":"Biol Psychiatry"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3389\/fncel.2019.00083","volume":"13","author":"Maguire J.","year":"2019","unstructured":"Maguire J.; Neuroactive steroids and GABAergic involvement in the neuroendocrine dysfunction associated with major depressive disorder and postpartum depression. Front Cell Neurosci 2019,13,83","journal-title":"Front Cell Neurosci"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"557","DOI":"10.2147\/NDT.S245282","volume":"16","author":"Xu S.","year":"2020","unstructured":"Xu S.; Liu Y.; Pu J.; Gui S.; Zhong X.; Tian L.; Song X.; Qi X.; Wang H.; Xie P.; Chronic stress in a rat model of depression disturbs the glutamine-glutamate-GABA cycle in the striatum, hippocampus, and cerebellum. Neuropsychiatr Dis Treat 2020,16,557-570","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1476-5381.2010.01004.x","volume":"162","author":"Ghose S.","year":"2011","unstructured":"Ghose S.; Winter M.K.; McCarson K.E.; Tamminga C.A.; Enna S.J.; The GABA; receptor as a target for antidepressant drug action. Br J Pharmacol 2011,162(1),1-17","journal-title":"Br J Pharmacol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.drudis.2018.11.007","volume":"24","author":"Wilkinson S.T.","year":"2019","unstructured":"Wilkinson S.T.; Sanacora G.; A new generation of antidepressants: an update on the pharmaceutical pipeline for novel and rapid-acting therapeutics in mood disorders based on glutamate\/GABA neurotransmitter systems. Drug Discov Today 2019,24(2),606-615","journal-title":"Drug Discov Today"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0165-6147(85)90096-3","volume":"6","author":"Erd\u00f6 S.L.","year":"1985","unstructured":"Erd\u00f6 S.L.; Peripheral GABAergic mechanisms. Trends Pharmacol Sci 1985,6,205-208","journal-title":"Trends Pharmacol Sci"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.jff.2014.07.004","volume":"10","author":"Diana M.","year":"2014","unstructured":"Diana M.; Qu\u00edlez J.; Rafecas M.; Gamma-aminobutyric acid as a bioactive compound in foods: a review. J Funct Foods 2014,10,407-420","journal-title":"J Funct Foods"},{"key":"ref=36","author":"Martin D.L.","year":"2000","unstructured":"Martin D.L.; Olsen R.W.;  GABA in the Nervous System: The View at 50 Years 2000","journal-title":"GABA in the Nervous System: The View at 50 Years"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/0896-6273(91)90077-D","volume":"7","author":"Erlander M.G.","year":"1991","unstructured":"Erlander M.G.; Tillakaratne N.J.; Feldblum S.; Patel N.; Tobin A.J.; Two genes encode distinct glutamate decarboxylases. Neuron 1991,7(1),91-100","journal-title":"Neuron"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"5938","DOI":"10.1523\/JNEUROSCI.18-15-05938.1998","volume":"18","author":"Bowers G.","year":"1998","unstructured":"Bowers G.; Cullinan W.E.; Herman J.P.; Region-specific regulation of glutamic acid decarboxylase (GAD) mRNA expression in central stress circuits. J Neurosci 1998,18(15),5938-5947","journal-title":"J Neurosci"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/j.1471-4159.1993.tb03165.x","volume":"60","author":"Martin D.L.","year":"1993","unstructured":"Martin D.L.; Rimvall K.; Regulation of gamma-aminobutyric acid synthesis in the brain. J Neurochem 1993,60(2),395-407","journal-title":"J Neurochem"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S0306-4522(02)00864-3","volume":"117","author":"Minelli A.","year":"2003","unstructured":"Minelli A.; Alonso-Nanclares L.; Edwards R.H.; DeFelipe J.; Conti F.; Postnatal development of the vesicular GABA transporter in rat cerebral cortex. Neuroscience 2003,117(2),337-346","journal-title":"Neuroscience"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1111\/j.1471-4159.2006.03913.x","volume":"98","author":"Bak L.K.","year":"2006","unstructured":"Bak L.K.; Schousboe A.; Waagepetersen H.S.; The glutamate\/GABA-glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer. J Neurochem 2006,98(3),641-653","journal-title":"J Neurochem"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1097\/00004647-200110000-00012","volume":"21","author":"Takanaga H.","year":"2001","unstructured":"Takanaga H.; Ohtsuki S.; Hosoya K.; Terasaki T.; GAT2\/BGT-1 as a system responsible for the transport of gamma-aminobutyric acid at the mouse blood-brain barrier. J Cereb Blood Flow Metab 2001,21(10),1232-1239","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/j.1471-4159.2009.05982.x","volume":"109","author":"Madsen K.K.","year":"2009","unstructured":"Madsen K.K.; Clausen R.P.; Larsson O.M.; Krogsgaard-Larsen P.; Schousboe A.; White H.S.; Synaptic and extrasynaptic GABA transporters as targets for anti-epileptic drugs. J Neurochem 2009,109(Suppl. 1),139-144","journal-title":"J Neurochem"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1146\/annurev.ne.17.030194.003033","volume":"17","author":"Macdonald R.L.","year":"1994","unstructured":"Macdonald R.L.; Olsen R.W.; GABAA receptor channels. Annu Rev Neurosci 1994,17,569-602","journal-title":"Annu Rev Neurosci"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3389\/fncir.2014.00003","volume":"8","author":"Lee V.","year":"2014","unstructured":"Lee V.; Maguire J.; The impact of tonic GABAA receptor-mediated inhibition on neuronal excitability varies across brain region and cell type. Front Neural Circuits 2014,8,3","journal-title":"Front Neural Circuits"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"795","DOI":"10.2174\/1568026023393507","volume":"2","author":"Sieghart W.","year":"2002","unstructured":"Sieghart W.; Sperk G.; Subunit composition, distribution and function of GABA(A) receptor subtypes. Curr Top Med Chem 2002,2(8),795-816","journal-title":"Curr Top Med Chem"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/0301-0082(95)00012-K","volume":"46","author":"Misgeld U.","year":"1995","unstructured":"Misgeld U.; Bijak M.; Jarolimek W.; A physiological role for GABAB receptors and the effects of baclofen in the mammalian central nervous system. Prog Neurobiol 1995,46(4),423-462","journal-title":"Prog Neurobiol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1006\/mcne.2000.0908","volume":"16","author":"Couve A.","year":"2000","unstructured":"Couve A.; Moss S.J.; Pangalos M.N.; GABAB receptors: A new paradigm in G protein signaling. Mol Cell Neurosci 2000,16(4),296-312","journal-title":"Mol Cell Neurosci"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S1054-3589(10)58006-2","volume":"58","author":"Padgett C.L.","year":"2010","unstructured":"Padgett C.L.; Slesinger P.A.; GABAB receptor coupling to G-proteins and ion channels. Adv Pharmacol 2010,58,123-147","journal-title":"Adv Pharmacol"},{"key":"ref=50","first-page":"291","volume":"50","author":"Barnard E.A.","year":"1998","unstructured":"Barnard E.A.; Skolnick P.; Olsen R.W.; Mohler H.; Sieghart W.; Biggio G.; Braestrup C.; Bateson A.N.; Langer S.Z.; International Union of Pharmacology. XV. Subtypes of gamma-aminobutyric acidA receptors: Classification on the basis of subunit structure and receptor function. Pharmacol Rev 1998,50(2),291-313","journal-title":"Pharmacol Rev"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nrn3444","volume":"14","author":"DeFelipe J.","year":"2013","unstructured":"DeFelipe J.; L\u00f3pez-Cruz P.L.; Benavides-Piccione R.; Bielza C.; Larra\u00f1aga P.; Anderson S.; Burkhalter A.; Cauli B.; Fair\u00e9n A.; Feldmeyer D.; Fishell G.; Fitzpatrick D.; Freund T.F.; Gonz\u00e1lez-Burgos G.; Hestrin S.; Hill S.; Hof P.R.; Huang J.; Jones E.G.; Kawaguchi Y.; Kisv\u00e1rday Z.; Kubota Y.; Lewis D.A.; Mar\u00edn O.; Markram H.; McBain C.J.; Meyer H.S.; Monyer H.; Nelson S.B.; Rockland K.; Rossier J.; Rubenstein J.L.; Rudy B.; Scanziani M.; Shepherd G.M.; Sherwood C.C.; Staiger J.F.; Tam\u00e1s G.; Thomson A.; Wang Y.; Yuste R.; Ascoli G.A.; New insights into the classification and nomenclature of cortical GABAergic interneurons. Nat Rev Neurosci 2013,14(3),202-216","journal-title":"Nat Rev Neurosci"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"562","DOI":"10.3389\/fnins.2018.00562","volume":"12","author":"Jie F.","year":"2018","unstructured":"Jie F.; Yin G.; Yang W.; Yang M.; Gao S.; Lv J.; Li B.; Stress in regulation of GABA amygdala system and relevance to neuropsychiatric diseases. Front Neurosci 2018,12,562","journal-title":"Front Neurosci"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S0306-4522(02)00034-9","volume":"111","author":"Gottesmann C.","year":"2002","unstructured":"Gottesmann C.; GABA mechanisms and sleep. Neuroscience 2002,111(2),231-239","journal-title":"Neuroscience"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.cub.2011.01.069","volume":"21","author":"Stagg C.J.","year":"2011","unstructured":"Stagg C.J.; Bachtiar V.; Johansen-Berg H.; The role of GABA in human motor learning. Curr Biol 2011,21(6),480-484","journal-title":"Curr Biol"},{"key":"ref=55","first-page":"165","volume":"11","author":"Nuss P.","year":"2015","unstructured":"Nuss P.; Anxiety disorders and GABA neurotransmission: A disturbance of modulation. Neuropsychiatr Dis Treat 2015,11,165-175","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1113\/jphysiol.2008.167635","volume":"587","author":"Wang D.D.","year":"2009","unstructured":"Wang D.D.; Kriegstein A.R.; Defining the role of GABA in cortical development. J Physiol 2009,587(Pt 9),1873-1879","journal-title":"J Physiol"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.neuroimage.2013.10.059","volume":"87","author":"Sandberg K.","year":"2014","unstructured":"Sandberg K.; Blicher J.U.; Dong M.Y.; Rees G.; Near J.; Kanai R.; Occipital GABA correlates with cognitive failures in daily life. Neuroimage 2014,87(100),55-60","journal-title":"Neuroimage"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.1002\/jnr.21728","volume":"86","author":"Zhou C.","year":"2008","unstructured":"Zhou C.; Li C.; Yu H.M.; Zhang F.; Han D.; Zhang G.Y.; Neuroprotection of gamma-aminobutyric acid receptor agonists via enhancing neuronal nitric oxide synthase (Ser847) phosphorylation through increased neuronal nitric oxide synthase and PSD95 interaction and inhibited protein phosphatase activity in cerebral ischemia. J Neurosci Res 2008,86(13),2973-2983","journal-title":"J Neurosci Res"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/cne.22212","volume":"518","author":"Waldvogel H.J.","year":"2010","unstructured":"Waldvogel H.J.; Baer K.; Eady E.; Allen K.L.; Gilbert R.T.; Mohler H.; Rees M.I.; Nicholson L.F.; Faull R.L.; Differential localization of gamma-aminobutyric acid type A and glycine receptor subunits and gephyrin in the human pons, medulla oblongata and uppermost cervical segment of the spinal cord: an immunohistochemical study. J Comp Neurol 2010,518(3),305-328","journal-title":"J Comp Neurol"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"11692","DOI":"10.1073\/pnas.1102715108","volume":"108","author":"Soltani N.","year":"2011","unstructured":"Soltani N.; Qiu H.; Aleksic M.; Glinka Y.; Zhao F.; Liu R.; Li Y.; Zhang N.; Chakrabarti R.; Ng T.; Jin T.; Zhang H.; Lu W.Y.; Feng Z.P.; Prud\u2019homme G.J.; Wang Q.; GABA exerts protective and regenerative effects on islet beta cells and reverses diabetes. Proc Natl Acad Sci USA 2011,108(28),11692-11697","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=61","first-page":"47","volume":"61","author":"Hori A.","year":"2008","unstructured":"Hori A.; Hara T.; Honma K.; Joh T.; Suppressive effect of \u03b3-aminobutyric acid (GABA) on histamine release in rat basophilic RBL-2H3 cells. Niigata Daigaku Nogakubu Kenkyu Hokoku 2008,61,47-51","journal-title":"Niigata Daigaku Nogakubu Kenkyu Hokoku"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1089\/109662004322984653","volume":"7","author":"Oh C.H.","year":"2004","unstructured":"Oh C.H.; Oh S.H.; Effects of germinated brown rice extracts with enhanced levels of GABA on cancer cell proliferation and apoptosis. J Med Food 2004,7(1),19-23","journal-title":"J Med Food"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"527","DOI":"10.3389\/fmicb.2019.00527","volume":"10","author":"Sokovic Bajic S.","year":"2019","unstructured":"Sokovic Bajic S.; Djokic J.; Dinic M.; Veljovic K.; Golic N.; Mihajlovic S.; Tolinacki M.; GABA-producing natural dairy isolate from artisanal zlatar cheese attenuates gut inflammation and strengthens gut epithelial barrier in vitro. Front Microbiol 2019,10,527","journal-title":"Front Microbiol"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.cbpc.2018.11.018","volume":"217","author":"Zhu Z.","year":"2019","unstructured":"Zhu Z.; Shi Z.; Xie C.; Gong W.; Hu Z.; Peng Y.; A novel mechanism of Gamma-aminobutyric acid (GABA) protecting human umbilical vein endothelial cells (HUVECs) against HO-induced oxidative injury. Comp Biochem Physiol C Toxicol Pharmacol 2019,217,68-75","journal-title":"Comp Biochem Physiol C Toxicol Pharmacol"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/BF01256464","volume":"64","author":"Suzdak P.D.","year":"1985","unstructured":"Suzdak P.D.; Gianutsos G.; GABA-noradrenergic interaction: Evidence for differential sites of action for GABA-A and GABA-B receptors. J Neural Transm (Vienna) 1985,64(3-4),163-172","journal-title":"J Neural Transm (Vienna)"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1124\/jpet.104.073536","volume":"312","author":"Slattery D.A.","year":"2005","unstructured":"Slattery D.A.; Desrayaud S.; Cryan J.F.; GABAB receptor antagonist-mediated antidepressant-like behavior is serotonin-dependent. J Pharmacol Exp Ther 2005,312(1),290-296","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"6172","DOI":"10.3390\/ijms20246172","volume":"20","author":"Bhandage A.K.","year":"2019","unstructured":"Bhandage A.K.; Cunningham J.L.; Jin Z.; Shen Q.; Bongiovanni S.; Korol S.V.; Syk M.; Kamali-Moghaddam M.; Ekselius L.; Birnir B.; Depression, GABA, and age correlate with plasma levels of inflammatory markers. Int J Mol Sci 2019,20(24),6172","journal-title":"Int J Mol Sci"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1017\/S1092852919001159","volume":"24","author":"Ragguett R.M.","year":"2019","unstructured":"Ragguett R.M.; Tamura J.K.; McIntyre R.S.; Keeping up with the clinical advances: depression. CNS Spectr 2019,24(S1),25-37","journal-title":"CNS Spectr"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/sj.mp.4001362","volume":"8","author":"Brambilla P.","year":"2003","unstructured":"Brambilla P.; Perez J.; Barale F.; Schettini G.; Soares J.C.; GABAergic dysfunction in mood disorders. Mol Psychiatry 2003,8(8),721-737, 715","journal-title":"Mol Psychiatry"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/mp.2010.120","volume":"16","author":"Luscher B.","year":"2011","unstructured":"Luscher B.; Shen Q.; Sahir N.; The GABAergic deficit hypothesis of major depressive disorder. Mol Psychiatry 2011,16(4),383-406","journal-title":"Mol Psychiatry"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"603","DOI":"10.2147\/DDDT.S62912","volume":"9","author":"Pehrson A.L.","year":"2015","unstructured":"Pehrson A.L.; Sanchez C.; Altered \u03b3-aminobutyric acid neurotransmission in major depressive disorder: a critical review of the supporting evidence and the influence of serotonergic antidepressants. Drug Des Devel Ther 2015,9,603-624","journal-title":"Drug Des Devel Ther"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1113\/jphysiol.1987.sp016862","volume":"394","author":"Andrade R.","year":"1987","unstructured":"Andrade R.; Nicoll R.A.; Pharmacologically distinct actions of serotonin on single pyramidal neurones of the rat hippocampus recorded in vitro. J Physiol 1987,394(1),99-124","journal-title":"J Physiol"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1113\/jphysiol.1991.sp018742","volume":"441","author":"Ropert N.","year":"1991","unstructured":"Ropert N.; Guy N.; Serotonin facilitates GABAergic transmission in the CA1 region of rat hippocampus in vitro. J Physiol 1991,441,121-136","journal-title":"J Physiol"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1152\/jn.1998.79.2.937","volume":"79","author":"Bennett B.D.","year":"1998","unstructured":"Bennett B.D.; Huguenard J.R.; Prince D.A.; Adrenergic modulation of GABAA receptor-mediated inhibition in rat sensorimotor cortex. J Neurophysiol 1998,79(2),937-946","journal-title":"J Neurophysiol"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.neuroscience.2008.09.029","volume":"157","author":"Kaneko K.","year":"2008","unstructured":"Kaneko K.; Tamamaki N.; Owada H.; Kakizaki T.; Kume N.; Totsuka M.; Yamamoto T.; Yawo H.; Yagi T.; Obata K.; Yanagawa Y.; Noradrenergic excitation of a subpopulation of GABAergic cells in the basolateral amygdala via both activation of nonselective cationic conductance and suppression of resting K+ conductance: a study using glutamate decarboxylase 67-green fluorescent protein knock-in mice. Neuroscience 2008,157(4),781-797","journal-title":"Neuroscience"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.1523\/JNEUROSCI.20-08-02758.2000","volume":"20","author":"Sibille E.","year":"2000","unstructured":"Sibille E.; Pavlides C.; Benke D.; Toth M.; Genetic inactivation of the Serotonin(1A) receptor in mice results in downregulation of major GABA(A) receptor \u03b1 subunits, reduction of GABA(A) receptor binding, and benzodiazepine-resistant anxiety. J Neurosci 2000,20(8),2758-2765","journal-title":"J Neurosci"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/sj.bjp.0706935","volume":"149","author":"Boothman L.","year":"2006","unstructured":"Boothman L.; Raley J.; Denk F.; Hirani E.; Sharp T.; In vivo evidence that 5-HT(2C) receptors inhibit 5-HT neuronal activity via a GABAergic mechanism. Br J Pharmacol 2006,149(7),861-869","journal-title":"Br J Pharmacol"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"3018","DOI":"10.1016\/j.celrep.2017.02.077","volume":"18","author":"Zhou L.","year":"2017","unstructured":"Zhou L.; Liu M.Z.; Li Q.; Deng J.; Mu D.; Sun Y.G.; Organization of functional long-range circuits controlling the activity of serotonergic neurons in the dorsal raphe nucleus. Cell Rep 2017,18(12),3018-3032","journal-title":"Cell Rep"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"6963","DOI":"10.1523\/JNEUROSCI.18-17-06963.1998","volume":"18","author":"Kawaguchi Y.","year":"1998","unstructured":"Kawaguchi Y.; Shindou T.; Noradrenergic excitation and inhibition of GABAergic cell types in rat frontal cortex. J Neurosci 1998,18(17),6963-6976","journal-title":"J Neurosci"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1111\/j.1460-9568.2011.07614.x","volume":"33","author":"Samuels B.A.","year":"2011","unstructured":"Samuels B.A.; Hen R.; Neurogenesis and affective disorders. Eur J Neurosci 2011,33(6),1152-1159","journal-title":"Eur J Neurosci"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1097\/FBP.0b013e3282ee2aa8","volume":"18","author":"Schmidt H.D.","year":"2007","unstructured":"Schmidt H.D.; Duman R.S.; The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior. Behav Pharmacol 2007,18(5-6),391-418","journal-title":"Behav Pharmacol"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1111\/ejn.12335","volume":"38","author":"Luscher B.","year":"2013","unstructured":"Luscher B.; Fuchs T.; Adult hippocampal neurogenesis in the absence of serotonin (Commentary on Diaz et al.). Eur J Neurosci 2013,38(5),2649","journal-title":"Eur J Neurosci"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1111\/j.1460-9568.2011.07782.x","volume":"34","author":"Duveau V.","year":"2011","unstructured":"Duveau V.; Laustela S.; Barth L.; Gianolini F.; Vogt K.E.; Keist R.; Chandra D.; Homanics G.E.; Rudolph U.; Fritschy J.M.; Spatiotemporal specificity of GABAA receptor-mediated regulation of adult hippocampal neurogenesis. Eur J Neurosci 2011,34(3),362-373","journal-title":"Eur J Neurosci"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.neuropharm.2014.07.019","volume":"88","author":"Ren Z.","year":"2015","unstructured":"Ren Z.; Sahir N.; Murakami S.; Luellen B.A.; Earnheart J.C.; Lal R.; Kim J.Y.; Song H.; Luscher B.; Defects in dendrite and spine maturation and synaptogenesis associated with an anxious-depressive-like phenotype of GABAA receptor-deficient mice. Neuropharmacology 2015,88,171-179","journal-title":"Neuropharmacology"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.neuron.2005.08.023","volume":"47","author":"Tozuka Y.","year":"2005","unstructured":"Tozuka Y.; Fukuda S.; Namba T.; Seki T.; Hisatsune T.; GABAergic excitation promotes neuronal differentiation in adult hippocampal progenitor cells. Neuron 2005,47(6),803-815","journal-title":"Neuron"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"3845","DOI":"10.1523\/JNEUROSCI.3609-06.2007","volume":"27","author":"Earnheart J.C.","year":"2007","unstructured":"Earnheart J.C.; Schweizer C.; Crestani F.; Iwasato T.; Itohara S.; Mohler H.; L\u00fcscher B.; GABAergic control of adult hippocampal neurogenesis in relation to behavior indicative of trait anxiety and depression states. J Neurosci 2007,27(14),3845-3854","journal-title":"J Neurosci"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"5000","DOI":"10.1523\/JNEUROSCI.0143-04.2004","volume":"24","author":"Tan H.","year":"2004","unstructured":"Tan H.; Zhong P.; Yan Z.; Corticotropin-releasing factor and acute stress prolongs serotonergic regulation of GABA transmission in prefrontal cortical pyramidal neurons. J Neurosci 2004,24(21),5000-5008","journal-title":"J Neurosci"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/cne.20360","volume":"482","author":"Waselus M.","year":"2005","unstructured":"Waselus M.; Valentino R.J.; Van Bockstaele E.J.; Ultrastructural evidence for a role of gamma-aminobutyric acid in mediating the effects of corticotropin-releasing factor on the rat dorsal raphe serotonin system. J Comp Neurol 2005,482(2),155-165","journal-title":"J Comp Neurol"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"7330","DOI":"10.1523\/JNEUROSCI.5924-08.2009","volume":"29","author":"Radley J.J.","year":"2009","unstructured":"Radley J.J.; Gosselink K.L.; Sawchenko P.E.; A discrete GABAergic relay mediates medial prefrontal cortical inhibition of the neuroendocrine stress response. J Neurosci 2009,29(22),7330-7340","journal-title":"J Neurosci"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/S0006-8993(00)03000-6","volume":"887","author":"Cullinan W.E.","year":"2000","unstructured":"Cullinan W.E.; Wolfe T.J.; Chronic stress regulates levels of mRNA transcripts encoding beta subunits of the GABA(A) receptor in the rat stress axis. Brain Res 2000,887(1),118-124","journal-title":"Brain Res"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/mp.2014.68","volume":"19","author":"Northoff G.","year":"2014","unstructured":"Northoff G.; Sibille E.; Why are cortical GABA neurons relevant to internal focus in depression? A cross-level model linking cellular, biochemical and neural network findings. Mol Psychiatry 2014,19(9),966-977","journal-title":"Mol Psychiatry"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1523\/JNEUROSCI.21-01-00330.2001","volume":"21","author":"Orchinik M.","year":"2001","unstructured":"Orchinik M.; Carroll S.S.; Li Y.H.; McEwen B.S.; Weiland N.G.; Heterogeneity of hippocampal GABA(A) receptors: regulation by corticosterone. J Neurosci 2001,21(1),330-339","journal-title":"J Neurosci"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1002\/hipo.20758","volume":"21","author":"Holm M.M.","year":"2011","unstructured":"Holm M.M.; Nieto-Gonzalez J.L.; Vardya I.; Henningsen K.; Jayatissa M.N.; Wiborg O.; Jensen K.; Hippocampal GABAergic dysfunction in a rat chronic mild stress model of depression. Hippocampus 2011,21(4),422-433","journal-title":"Hippocampus"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1007\/s11064-014-1282-6","volume":"39","author":"Cushman J.D.","year":"2014","unstructured":"Cushman J.D.; Moore M.D.; Olsen R.W.; Fanselow M.S.; The role of the \u03b4 GABA(A) receptor in ovarian cycle-linked changes in hippocampus-dependent learning and memory. Neurochem Res 2014,39(6),1140-1146","journal-title":"Neurochem Res"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/S0006-3223(00)00994-X","volume":"48","author":"Sheline Y.I.","year":"2000","unstructured":"Sheline Y.I.; 3D MRI studies of neuroanatomic changes in unipolar major depression: the role of stress and medical comorbidity. Biol Psychiatry 2000,48(8),791-800","journal-title":"Biol Psychiatry"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1073\/pnas.0337481100","volume":"100","author":"MacQueen G.M.","year":"2003","unstructured":"MacQueen G.M.; Campbell S.; McEwen B.S.; Macdonald K.; Amano S.; Joffe R.T.; Nahmias C.; Young L.T.; Course of illness, hippocampal function, and hippocampal volume in major depression. Proc Natl Acad Sci USA 2003,100(3),1387-1392","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/npp.2009.104","volume":"35","author":"Price J.L.","year":"2010","unstructured":"Price J.L.; Drevets W.C.; Neurocircuitry of mood disorders. Neuropsychopharmacology 2010,35(1),192-216","journal-title":"Neuropsychopharmacology"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"9104","DOI":"10.1523\/JNEUROSCI.20-24-09104.2000","volume":"20","author":"Malberg J.E.","year":"2000","unstructured":"Malberg J.E.; Eisch A.J.; Nestler E.J.; Duman R.S.; Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 2000,20(24),9104-9110","journal-title":"J Neurosci"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.brainres.2005.01.007","volume":"1037","author":"Hoshaw B.A.","year":"2005","unstructured":"Hoshaw B.A.; Malberg J.E.; Lucki I.; Central administration of IGF-I and BDNF leads to long-lasting antidepressant-like effects. Brain Res 2005,1037(1-2),204-208","journal-title":"Brain Res"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.cell.2021.01.034","volume":"184","author":"Casarotto P.C.","year":"2021","unstructured":"Casarotto P.C.; Girych M.; Fred S.M.; Kovaleva V.; Moliner R.; Enkavi G.; Biojone C.; Cannarozzo C.; Sahu M.P.; Kaurinkoski K.; Brunello C.A.; Steinzeig A.; Winkel F.; Patil S.; Vestring S.; Serchov T.; Diniz C.R.A.F.; Laukkanen L.; Cardon I.; Antila H.; Rog T.; Piepponen T.P.; Bramham C.R.; Normann C.; Lauri S.E.; Saarma M.; Vattulainen I.; Castr\u00e9n E.; Antidepressant drugs act by directly binding to TRKB neurotrophin receptors. Cell 2021,184(5),1299-1313","journal-title":"Cell"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/ejn.14630","volume":"53","author":"Duman R.S.","year":"2021","unstructured":"Duman R.S.; Deyama S.; Foga\u00e7a M.V.; Role of BDNF in the pathophysiology and treatment of depression: activity-dependent effects distinguish rapid-acting antidepressants. Eur J Neurosci 2021,53(1),126-139","journal-title":"Eur J Neurosci"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s00221-009-1994-z","volume":"199","author":"Gottmann K.","year":"2009","unstructured":"Gottmann K.; Mittmann T.; Lessmann V.; BDNF signaling in the formation, maturation and plasticity of glutamatergic and GABAergic synapses. Exp Brain Res 2009,199(3-4),203-234","journal-title":"Exp Brain Res"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3389\/fncel.2018.00273","volume":"12","author":"Porcher C.","year":"2018","unstructured":"Porcher C.; Medina I.; Gaiarsa J.L.; Mechanism of BDNF modulation in GABAergic synaptic transmission in healthy and disease brains. Front Cell Neurosci 2018,12,273","journal-title":"Front Cell Neurosci"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1093\/cercor\/bhh130","volume":"15","author":"Ohba S.","year":"2005","unstructured":"Ohba S.; Ikeda T.; Ikegaya Y.; Nishiyama N.; Matsuki N.; Yamada M.K.; BDNF locally potentiates GABAergic presynaptic machineries: target-selective circuit inhibition. Cereb Cortex 2005,15(3),291-298","journal-title":"Cereb Cortex"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"108412","DOI":"10.1016\/j.neuropharm.2020.108412","volume":"184","author":"Xu H.","year":"2021","unstructured":"Xu H.; Wang J.; Jing H.; Ellenbroek B.; Shao F.; Wang W.; mPFC GABAergic transmission mediated the role of BDNF signaling in cognitive impairment but not anxiety induced by adolescent social stress. Neuropharmacology 2021,184,108412","journal-title":"Neuropharmacology"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/nri.2015.5","volume":"16","author":"Miller A.H.","year":"2016","unstructured":"Miller A.H.; Raison C.L.; The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol 2016,16(1),22-34","journal-title":"Nat Rev Immunol"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/978-0-585-37970-8_2","volume":"461","author":"Maes M.","year":"1999","unstructured":"Maes M.; Major depression and activation of the inflammatory response system. Adv Exp Med Biol 1999,461,25-46","journal-title":"Adv Exp Med Biol"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/s12640-010-9210-2","volume":"19","author":"M\u00fcller N.","year":"2011","unstructured":"M\u00fcller N.; Myint A.M.; Schwarz M.J.; Inflammatory biomarkers and depression. Neurotox Res 2011,19(2),308-318","journal-title":"Neurotox Res"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.jpsychires.2013.05.018","volume":"47","author":"Munkholm K.","year":"2013","unstructured":"Munkholm K.; Bra\u00fcner J.V.; Kessing L.V.; Vinberg M.; Cytokines in bipolar disorder vs. healthy control subjects: A systematic review and meta-analysis. J Psychiatr Res 2013,47(9),1119-1133","journal-title":"J Psychiatr Res"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/glia.21087","volume":"59","author":"Lee M.","year":"2011","unstructured":"Lee M.; Schwab C.; McGeer P.L.; Astrocytes are GABAergic cells that modulate microglial activity. Glia 2011,59(1),152-165","journal-title":"Glia"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jad.2014.07.032","volume":"169","author":"Young J.J.","year":"2014","unstructured":"Young J.J.; Bruno D.; Pomara N.; A review of the relationship between proinflammatory cytokines and major depressive disorder. J Affect Disord 2014,169,15-20","journal-title":"J Affect Disord"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"448","DOI":"10.4172\/Neuropsychiatry.1000236","volume":"7","author":"Amodeo G.","year":"2018","unstructured":"Amodeo G.; Trusso M.A.; Fagiolini A.; Depression and inflammation: disentangling a clear yet complex and multifaceted link. Neuropsychiatry (London) 2018,7(4),448-457","journal-title":"Neuropsychiatry (London)"},{"key":"ref=113","first-page":"10","volume":"2013","author":"Raison C.L.","year":"2013","unstructured":"Raison C.L.; Miller A.H.; Do cytokines really sing the blues? Cerebrum 2013,2013,10","journal-title":"Cerebrum"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"447","DOI":"10.3389\/fnins.2014.00447","volume":"8","author":"Wohleb E.S.","year":"2015","unstructured":"Wohleb E.S.; McKim D.B.; Sheridan J.F.; Godbout J.P.; Monocyte trafficking to the brain with stress and inflammation: A novel axis of immune-to-brain communication that influences mood and behavior. Front Neurosci 2015,8,447","journal-title":"Front Neurosci"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/apha.12440","volume":"213","author":"Bhandage A.K.","year":"2015","unstructured":"Bhandage A.K.; Hellgren C.; Jin Z.; Olafsson E.B.; Sundstr\u00f6m-Poromaa I.; Birnir B.; Expression of GABA receptors subunits in peripheral blood mononuclear cells is gender dependent, altered in pregnancy and modified by mental health. Acta Physiol (Oxf) 2015,213(3),575-585","journal-title":"Acta Physiol (Oxf)"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jneuroim.2008.08.017","volume":"205","author":"Bjurst\u00f6m H.","year":"2008","unstructured":"Bjurst\u00f6m H.; Wang J.; Ericsson I.; Bengtsson M.; Liu Y.; Kumar-Mendu S.; Issazadeh-Navikas S.; Birnir B.; GABA, a natural immunomodulator of T lymphocytes. J Neuroimmunol 2008,205(1-2),44-50","journal-title":"J Neuroimmunol"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1146\/annurev-pathol-051217-111018","volume":"13","author":"Plog B.A.","year":"2018","unstructured":"Plog B.A.; Nedergaard M.; The glymphatic system in central nervous system health and disease: past, present, and future. Annu Rev Pathol 2018,13,379-394","journal-title":"Annu Rev Pathol"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1111\/j.1471-4159.1982.tb05350.x","volume":"38","author":"L\u00f6scher W.","year":"1982","unstructured":"L\u00f6scher W.; Frey H.H.; Transport of GABA at the blood-CSF interface. J Neurochem 1982,38(4),1072-1079","journal-title":"J Neurochem"},{"key":"ref=119","first-page":"185","volume":"18","author":"Berrettini W.H.","year":"1983","unstructured":"Berrettini W.H.; Nurnberger J.I.; Hare T.A.; Simmons-Alling S.; Gershon E.S.; Post R.M.; Reduced plasma and CSF gamma-aminobutyric acid in affective illness: effect of lithium carbonate. Biol Psychiatry 1983,18(2),185-194","journal-title":"Biol Psychiatry"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.bbi.2016.02.001","volume":"54","author":"Crowley T.","year":"2016","unstructured":"Crowley T.; Cryan J.F.; Downer E.J.; O\u2019Leary O.F.; Inhibiting neuroinflammation: the role and therapeutic potential of GABA in neuro-immune interactions. Brain Behav Immun 2016,54,260-277","journal-title":"Brain Behav Immun"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"429815","DOI":"10.1155\/2013\/429815","volume":"2013","author":"Ferrini F.","year":"2013","unstructured":"Ferrini F.; De Koninck Y.; Microglia control neuronal network excitability via BDNF signalling. Neural Plast 2013,2013,429815","journal-title":"Neural Plast"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1523\/JNEUROSCI.4486-04.2005","volume":"25","author":"Stellwagen D.","year":"2005","unstructured":"Stellwagen D.; Beattie E.C.; Seo J.Y.; Malenka R.C.; Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha. J Neurosci 2005,25(12),3219-3228","journal-title":"J Neurosci"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.cmet.2011.06.016","volume":"14","author":"Leinninger G.M.","year":"2011","unstructured":"Leinninger G.M.; Opland D.M.; Jo Y.H.; Faouzi M.; Christensen L.; Cappellucci L.A.; Rhodes C.J.; Gnegy M.E.; Becker J.B.; Pothos E.N.; Seasholtz A.F.; Thompson R.C.; Myers M.G.; Leptin action via neurotensin neurons controls orexin, the mesolimbic dopamine system and energy balance. Cell Metab 2011,14(3),313-323","journal-title":"Cell Metab"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1176\/ajp.137.3.362","volume":"137","author":"Gold B.I.","year":"1980","unstructured":"Gold B.I.; Bowers M.B.; Roth R.H.; Sweeney D.W.; GABA levels in CSF of patients with psychiatric disorders. Am J Psychiatry 1980,137(3),362-364","journal-title":"Am J Psychiatry"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1176\/ajp.138.8.1098","volume":"138","author":"Gerner R.H.","year":"1981","unstructured":"Gerner R.H.; Hare T.A.; CSF GABA in normal subjects and patients with depression, schizophrenia, mania, and anorexia nervosa. Am J Psychiatry 1981,138(8),1098-1101","journal-title":"Am J Psychiatry"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/0165-0327(81)90003-3","volume":"3","author":"Petty F.","year":"1981","unstructured":"Petty F.; Schlesser M.A.; Plasma GABA in affective illness. A preliminary investigation. J Affect Disord 1981,3(4),339-343","journal-title":"J Affect Disord"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1093\/clinchem\/40.2.296","volume":"40","author":"Petty F.","year":"1994","unstructured":"Petty F.; Plasma concentrations of gamma-aminobutyric acid (GABA) and mood disorders: a blood test for manic depressive disease? Clin Chem 1994,40(2),296-302","journal-title":"Clin Chem"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1196\/annals.1397.081","volume":"1096","author":"Bielau H.","year":"2007","unstructured":"Bielau H.; Steiner J.; Mawrin C.; Tr\u00fcbner K.; Brisch R.; Meyer-Lotz G.; Brodhun M.; Dobrowolny H.; Baumann B.; Gos T.; Bernstein H.G.; Bogerts B.; Dysregulation of GABAergic neurotransmission in mood disorders: A postmortem study. Ann N Y Acad Sci 2007,1096,157-169","journal-title":"Ann N Y Acad Sci"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jad.2008.04.021","volume":"113","author":"Gos T.","year":"2009","unstructured":"Gos T.; G\u00fcnther K.; Bielau H.; Dobrowolny H.; Mawrin C.; Tr\u00fcbner K.; Brisch R.; Steiner J.; Bernstein H.G.; Jankowski Z.; Bogerts B.; Suicide and depression in the quantitative analysis of glutamic acid decarboxylase-Immunoreactive neuropil. J Affect Disord 2009,113(1-2),45-55","journal-title":"J Affect Disord"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1017\/S1461145709990587","volume":"13","author":"Karolewicz B.","year":"2010","unstructured":"Karolewicz B.; Maciag D.; O\u2019Dwyer G.; Stockmeier C.A.; Feyissa A.M.; Rajkowska G.; Reduced level of glutamic acid decarboxylase-67 kDa in the prefrontal cortex in major depression. Int J Neuropsychopharmacol 2010,13(4),411-420","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1038\/mp.2011.113","volume":"17","author":"Guilloux J.P.","year":"2012","unstructured":"Guilloux J.P.; Douillard-Guilloux G.; Kota R.; Wang X.; Gardier A.M.; Martinowich K.; Tseng G.C.; Lewis D.A.; Sibille E.; Molecular evidence for BDNF- and GABA-related dysfunctions in the amygdala of female subjects with major depression. Mol Psychiatry 2012,17(11),1130-1142","journal-title":"Mol Psychiatry"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1017\/S1461145710001616","volume":"14","author":"Sibille E.","year":"2011","unstructured":"Sibille E.; Morris H.M.; Kota R.S.; Lewis D.A.; GABA-related transcripts in the dorsolateral prefrontal cortex in mood disorders. Int J Neuropsychopharmacol 2011,14(6),721-734","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.nbd.2011.01.014","volume":"42","author":"Tripp A.","year":"2011","unstructured":"Tripp A.; Kota R.S.; Lewis D.A.; Sibille E.; Reduced somatostatin in subgenual anterior cingulate cortex in major depression. Neurobiol Dis 2011,42(1),116-124","journal-title":"Neurobiol Dis"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1038\/s41467-018-03811-x","volume":"9","author":"Anderson K.M.","year":"2018","unstructured":"Anderson K.M.; Krienen F.M.; Choi E.Y.; Reinen J.M.; Yeo B.T.T.; Holmes A.J.; Gene expression links functional networks across cortex and striatum. Nat Commun 2018,9(1),1428","journal-title":"Nat Commun"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.neuron.2016.06.033","volume":"91","author":"Tremblay R.","year":"2016","unstructured":"Tremblay R.; Lee S.; Rudy B.; GABAergic interneurons in the neocortex: from cellular properties to circuits. Neuron 2016,91(2),260-292","journal-title":"Neuron"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/mp.2014.184","volume":"20","author":"Lin L.C.","year":"2015","unstructured":"Lin L.C.; Sibille E.; Somatostatin, neuronal vulnerability and behavioral emotionality. Mol Psychiatry 2015,20(3),377-387","journal-title":"Mol Psychiatry"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/S2215-0366(16)30263-2","volume":"4","author":"Kuehner C.","year":"2017","unstructured":"Kuehner C.; Why is depression more common among women than among men? Lancet Psychiatry 2017,4(2),146-158","journal-title":"Lancet Psychiatry"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"e6585","DOI":"10.1371\/journal.pone.0006585","volume":"4","author":"Sequeira A.","year":"2009","unstructured":"Sequeira A.; Mamdani F.; Ernst C.; Vawter M.P.; Bunney W.E.; Lebel V.; Rehal S.; Klempan T.; Gratton A.; Benkelfat C.; Rouleau G.A.; Mechawar N.; Turecki G.; Global brain gene expression analysis links glutamatergic and GABAergic alterations to suicide and major depression. PLoS One 2009,4(8),e6585","journal-title":"PLoS One"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1523\/JNEUROSCI.4734-03.2004","volume":"24","author":"Merali Z.","year":"2004","unstructured":"Merali Z.; Du L.; Hrdina P.; Palkovits M.; Faludi G.; Poulter M.O.; Anisman H.; Dysregulation in the suicide brain: mRNA expression of corticotropin-releasing hormone receptors and GABA(A) receptor subunits in frontal cortical brain region. J Neurosci 2004,24(6),1478-1485","journal-title":"J Neurosci"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"15653","DOI":"10.1073\/pnas.0507901102","volume":"102","author":"Choudary P.V.","year":"2005","unstructured":"Choudary P.V.; Molnar M.; Evans S.J.; Tomita H.; Li J.Z.; Vawter M.P.; Myers R.M.; Bunney W.E.; Akil H.; Watson S.J.; Jones E.G.; Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression. Proc Natl Acad Sci USA 2005,102(43),15653-15658","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"13329","DOI":"10.1523\/JNEUROSCI.4083-07.2007","volume":"27","author":"Kang H.J.","year":"2007","unstructured":"Kang H.J.; Adams D.H.; Simen A.; Simen B.B.; Rajkowska G.; Stockmeier C.A.; Overholser J.C.; Meltzer H.Y.; Jurjus G.J.; Konick L.C.; Newton S.S.; Duman R.S.; Gene expression profiling in postmortem prefrontal cortex of major depressive disorder. J Neurosci 2007,27(48),13329-13340","journal-title":"J Neurosci"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/sj.mp.4001969","volume":"12","author":"Sequeira A.","year":"2007","unstructured":"Sequeira A.; Klempan T.; Canetti L.; ffrench-Mullen J.; Benkelfat C.; Rouleau G.A.; Turecki G.; Patterns of gene expression in the limbic system of suicides with and without major depression. Mol Psychiatry 2007,12(7),640-655","journal-title":"Mol Psychiatry"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.jpsychires.2018.04.020","volume":"102","author":"Zhao J.","year":"2018","unstructured":"Zhao J.; Verwer R.W.H.; Gao S.F.; Qi X.R.; Lucassen P.J.; Kessels H.W.; Swaab D.F.; Prefrontal alterations in GABAergic and glutamatergic gene expression in relation to depression and suicide. J Psychiatr Res 2018,102,261-274","journal-title":"J Psychiatr Res"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.schres.2010.12.025","volume":"128","author":"Fatemi S.H.","year":"2011","unstructured":"Fatemi S.H.; Folsom T.D.; Thuras P.D.; Deficits in GABA(B) receptor system in schizophrenia and mood disorders: a postmortem study. Schizophr Res 2011,128(1-3),37-43","journal-title":"Schizophr Res"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/0165-1781(88)90066-2","volume":"26","author":"Cross J.A.","year":"1988","unstructured":"Cross J.A.; Cheetham S.C.; Crompton M.R.; Katona C.L.; Horton R.W.; Brain GABAB binding sites in depressed suicide victims. Psychiatry Res 1988,26(2),119-129","journal-title":"Psychiatry Res"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1159\/000118893","volume":"26","author":"Arranz B.","year":"1992","unstructured":"Arranz B.; Cowburn R.; Eriksson A.; Vestling M.; Marcusson J.; Gamma-aminobutyric acid-B (GABAB) binding sites in postmortem suicide brains. Neuropsychobiology 1992,26(1-2),33-36","journal-title":"Neuropsychobiology"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1038\/s41467-020-16710-x","volume":"11","author":"Anderson K.M.","year":"2020","unstructured":"Anderson K.M.; Collins M.A.; Chin R.; Ge T.; Rosenberg M.D.; Holmes A.J.; Transcriptional and imaging-genetic association of cortical interneurons, brain function, and schizophrenia risk. Nat Commun 2020,11(1),2889","journal-title":"Nat Commun"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41467-017-02642-6","volume":"9","author":"Mariotti L.","year":"2018","unstructured":"Mariotti L.; Losi G.; Lia A.; Melone M.; Chiavegato A.; G\u00f3mez-Gonzalo M.; Sessolo M.; Bovetti S.; Forli A.; Zonta M.; Requie L.M.; Marcon I.; Pugliese A.; Viollet C.; Bettler B.; Fellin T.; Conti F.; Carmignoto G.; Interneuron-specific signaling evokes distinctive somatostatin-mediated responses in adult cortical astrocytes. Nat Commun 2018,9(1),82","journal-title":"Nat Commun"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"3358","DOI":"10.1038\/s41467-020-17051-5","volume":"11","author":"Seidlitz J.","year":"2020","unstructured":"Seidlitz J.; Nadig A.; Liu S.; Bethlehem R.A.I.; V\u00e9rtes P.E.; Morgan S.E.; V\u00e1\u0161a F.; Romero-Garcia R.; Lalonde F.M.; Clasen L.S.; Blumenthal J.D.; Paquola C.; Bernhardt B.; Wagstyl K.; Polioudakis D.; de la Torre-Ubieta L.; Geschwind D.H.; Han J.C.; Lee N.R.; Murphy D.G.; Bullmore E.T.; Raznahan A.; Transcriptomic and cellular decoding of regional brain vulnerability to neurogenetic disorders. Nat Commun 2020,11(1),3358","journal-title":"Nat Commun"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"437","DOI":"10.4161\/epi.27558","volume":"9","author":"Boersma G.J.","year":"2014","unstructured":"Boersma G.J.; Lee R.S.; Cordner Z.A.; Ewald E.R.; Purcell R.H.; Moghadam A.A.; Tamashiro K.L.; Prenatal stress decreases Bdnf expression and increases methylation of Bdnf exon IV in rats. Epigenetics 2014,9(3),437-447","journal-title":"Epigenetics"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.biopsych.2008.05.028","volume":"64","author":"Poulter M.O.","year":"2008","unstructured":"Poulter M.O.; Du L.; Weaver I.C.; Palkovits M.; Faludi G.; Merali Z.; Szyf M.; Anisman H.; GABAA receptor promoter hypermethylation in suicide brain: implications for the involvement of epigenetic processes. Biol Psychiatry 2008,64(8),645-652","journal-title":"Biol Psychiatry"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.neubiorev.2004.10.008","volume":"29","author":"de Kloet E.R.","year":"2005","unstructured":"de Kloet E.R.; Sibug R.M.; Helmerhorst F.M.; Schmidt M.V.; Stress, genes and the mechanism of programming the brain for later life [published correction appears in Neurosci. Biobehav. Rev. 2006, 30(4), 576. Schmidt, Mathias [corrected to Schmidt, Mathias V]]. Neurosci Biobehav Rev 2005,29(2),271-281","journal-title":"Neurosci Biobehav Rev"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1001\/archgenpsychiatry.2011.131","volume":"69","author":"Gabbay V.","year":"2012","unstructured":"Gabbay V.; Mao X.; Klein R.G.; Ely B.A.; Babb J.S.; Panzer A.M.; Alonso C.M.; Shungu D.C.; Anterior cingulate cortex \u03b3-aminobutyric acid in depressed adolescents: relationship to anhedonia. Arch Gen Psychiatry 2012,69(2),139-149","journal-title":"Arch Gen Psychiatry"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jpsychires.2018.08.015","volume":"105","author":"Godfrey K.E.M.","year":"2018","unstructured":"Godfrey K.E.M.; Gardner A.C.; Kwon S.; Chea W.; Muthukumaraswamy S.D.; Differences in excitatory and inhibitory neurotransmitter levels between depressed patients and healthy controls: a systematic review and meta-analysis. J Psychiatr Res 2018,105,33-44","journal-title":"J Psychiatr Res"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.jad.2020.05.026","volume":"274","author":"Benson K.L.","year":"2020","unstructured":"Benson K.L.; Bottary R.; Schoerning L.; Baer L.; Gonenc A.; Eric Jensen J.; Winkelman J.W.; 1H MRS measurement of cortical GABA and glutamate in primary insomnia and major depressive disorder: Relationship to sleep quality and depression severity. J Affect Disord 2020,274,624-631","journal-title":"J Affect Disord"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1176\/appi.ajp.159.4.663","volume":"159","author":"Sanacora G.","year":"2002","unstructured":"Sanacora G.; Mason G.F.; Rothman D.L.; Krystal J.H.; Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors. Am J Psychiatry 2002,159(4),663-665","journal-title":"Am J Psychiatry"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1176\/appi.ajp.161.2.368","volume":"161","author":"Bhagwagar Z.","year":"2004","unstructured":"Bhagwagar Z.; Wylezinska M.; Taylor M.; Jezzard P.; Matthews P.M.; Cowen P.J.; Increased brain GABA concentrations following acute administration of a selective serotonin reuptake inhibitor. Am J Psychiatry 2004,161(2),368-370","journal-title":"Am J Psychiatry"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"E37","DOI":"10.1503\/jpn.150223","volume":"41","author":"Dubin M.J.","year":"2016","unstructured":"Dubin M.J.; Mao X.; Banerjee S.; Goodman Z.; Lapidus K.A.; Kang G.; Liston C.; Shungu D.C.; Elevated prefrontal cortex GABA in patients with major depressive disorder after TMS treatment measured with\u00a0proton magnetic resonance spectroscopy. J Psychiatry Neurosci 2016,41(3),E37-E45","journal-title":"J Psychiatry Neurosci"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1176\/appi.ajp.160.3.577","volume":"160","author":"Sanacora G.","year":"2003","unstructured":"Sanacora G.; Mason G.F.; Rothman D.L.; Hyder F.; Ciarcia J.J.; Ostroff R.B.; Berman R.M.; Krystal J.H.; Increased cortical GABA concentrations in depressed patients receiving ECT. Am J Psychiatry 2003,160(3),577-579","journal-title":"Am J Psychiatry"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.biopsych.2005.07.015","volume":"59","author":"Sanacora G.","year":"2006","unstructured":"Sanacora G.; Fenton L.R.; Fasula M.K.; Rothman D.L.; Levin Y.; Krystal J.H.; Mason G.F.; Cortical gamma-aminobutyric acid concentrations in depressed patients receiving cognitive behavioral therapy. Biol Psychiatry 2006,59(3),284-286","journal-title":"Biol Psychiatry"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.biopsych.2009.09.025","volume":"67","author":"Levinson A.J.","year":"2010","unstructured":"Levinson A.J.; Fitzgerald P.B.; Favalli G.; Blumberger D.M.; Daigle M.; Daskalakis Z.J.; Evidence of cortical inhibitory deficits in major depressive disorder. Biol Psychiatry 2010,67(5),458-464","journal-title":"Biol Psychiatry"},{"key":"ref=162","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.clinph.2013.01.014","volume":"124","author":"Radhu N.","year":"2013","unstructured":"Radhu N.; de Jesus D.R.; Ravindran L.N.; Zanjani A.; Fitzgerald P.B.; Daskalakis Z.J.; A meta-analysis of cortical inhibition and excitability using transcranial magnetic stimulation in psychiatric disorders. Clin Neurophysiol 2013,124(7),1309-1320","journal-title":"Clin Neurophysiol"},{"key":"ref=163","doi-asserted-by":"publisher","first-page":"3337","DOI":"10.1002\/hbm.23244","volume":"37","author":"Sch\u00fcr R.R.","year":"2016","unstructured":"Sch\u00fcr R.R.; Draisma L.W.; Wijnen J.P.; Boks M.P.; Koevoets M.G.; Jo\u00ebls M.; Klomp D.W.; Kahn R.S.; Vinkers C.H.; Brain GABA levels across psychiatric disorders: A systematic literature review and meta-analysis of (1) H-MRS studies. Hum Brain Mapp 2016,37(9),3337-3352","journal-title":"Hum Brain Mapp"},{"key":"ref=164","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.jad.2020.01.138","volume":"266","author":"Draganov M.","year":"2020","unstructured":"Draganov M.; Vives-Gilabert Y.; de Diego-Adeli\u00f1o J.; Vicent-Gil M.; Puigdemont D.; Portella M.J.; Glutamatergic and GABA-ergic abnormalities in First-episode depression. A 1-year follow-up 1H-MR spectroscopic study. J Affect Disord 2020,266,572-577","journal-title":"J Affect Disord"},{"key":"ref=165","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.pnpbp.2018.06.004","volume":"86","author":"Bradley K.A.","year":"2018","unstructured":"Bradley K.A.; Alonso C.M.; Mehra L.M.; Xu J.; Gabbay V.; Elevated striatal \u03b3-aminobutyric acid in youth with major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2018,86,203-210","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref=166","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/s00213-005-0213-2","volume":"186","author":"Pinna G.","year":"2006","unstructured":"Pinna G.; Costa E.; Guidotti A.; Fluoxetine and norfluoxetine stereospecifically and selectively increase brain neurosteroid content at doses that are inactive on 5-HT reuptake. Psychopharmacology (Berl) 2006,186(3),362-372","journal-title":"Psychopharmacology (Berl)"},{"key":"ref=167","doi-asserted-by":"publisher","first-page":"12905","DOI":"10.1073\/pnas.96.22.12905","volume":"96","author":"Mihalek R.M.","year":"1999","unstructured":"Mihalek R.M.; Banerjee P.K.; Korpi E.R.; Quinlan J.J.; Firestone L.L.; Mi Z.P.; Lagenaur C.; Tretter V.; Sieghart W.; Anagnostaras S.G.; Sage J.R.; Fanselow M.S.; Guidotti A.; Spigelman I.; Li Z.; DeLorey T.M.; Olsen R.W.; Homanics G.E.; Attenuated sensitivity to neuroactive steroids in \u03b3-aminobutyrate type A receptor delta subunit knockout mice. Proc Natl Acad Sci USA 1999,96(22),12905-12910","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=168","first-page":"805","volume":"285","author":"Shen R.Y.","year":"1998","unstructured":"Shen R.Y.; Andrade R.; 5-Hydroxytryptamine2 receptor facilitates GABAergic neurotransmission in rat hippocampus. J Pharmacol Exp Ther 1998,285(2),805-812","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=169","doi-asserted-by":"publisher","first-page":"15567","DOI":"10.1523\/JNEUROSCI.1845-13.2013","volume":"33","author":"Vithlani M.","year":"2013","unstructured":"Vithlani M.; Hines R.M.; Zhong P.; Terunuma M.; Hines D.J.; Revilla-Sanchez R.; Jurd R.; Haydon P.; Rios M.; Brandon N.; Yan Z.; Moss S.J.; The ability of BDNF to modify neurogenesis and depressive-like behaviors is dependent upon phosphorylation of tyrosine residues 365\/367 in the GABA(A)-receptor \u03b32 subunit. J Neurosci 2013,33(39),15567-15577","journal-title":"J Neurosci"},{"key":"ref=170","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/2798","volume":"1","author":"Essrich C.","year":"1998","unstructured":"Essrich C.; Lorez M.; Benson J.A.; Fritschy J.M.; L\u00fcscher B.; Postsynaptic clustering of major GABAA receptor subtypes requires the gamma 2 subunit and gephyrin. Nat Neurosci 1998,1(7),563-571","journal-title":"Nat Neurosci"},{"key":"ref=171","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","volume":"47","author":"Berman R.M.","year":"2000","unstructured":"Berman R.M.; Cappiello A.; Anand A.; Oren D.A.; Heninger G.R.; Charney D.S.; Krystal J.H.; Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 2000,47(4),351-354","journal-title":"Biol Psychiatry"},{"key":"ref=172","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2174\/1570159X14666160309114549","volume":"15","author":"Wohleb E.S.","year":"2017","unstructured":"Wohleb E.S.; Gerhard D.; Thomas A.; Duman R.S.; Molecular and cellular mechanisms of rapid-acting antidepressants ketamine and scopolamine. Curr Neuropharmacol 2017,15(1),11-20","journal-title":"Curr Neuropharmacol"},{"key":"ref=173","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/bs.apha.2020.03.002","volume":"89","author":"Luscher B.","year":"2020","unstructured":"Luscher B.; Feng M.; Jefferson S.J.; Antidepressant mechanisms of ketamine: focus on GABAergic inhibition. Adv Pharmacol 2020,89,43-78","journal-title":"Adv Pharmacol"},{"key":"ref=174","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1007\/s00210-020-01910-5","volume":"393","author":"Neis V.B.","year":"2020","unstructured":"Neis V.B.; Rosado A.F.; Olescowicz G.; Moretti M.; Rosa P.B.; Platt N.; Rodrigues A.L.S.; The involvement of GABAergic system in the antidepressant-like effect of agmatine. Naunyn Schmiedebergs Arch Pharmacol 2020,393(10),1931-1939","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"ref=175","doi-asserted-by":"publisher","first-page":"CD010677","DOI":"10.1002\/14651858.CD010677.pub2","volume":"3","author":"Breilmann J.","year":"2019","unstructured":"Breilmann J.; Girlanda F.; Guaiana G.; Barbui C.; Cipriani A.; Castellazzi M.; Bighelli I.; Davies S.J.; Furukawa T.A.; Koesters M.; Benzodiazepines versus placebo for panic disorder in adults. Cochrane Database Syst Rev 2019,3(3),CD010677","journal-title":"Cochrane Database Syst Rev"},{"key":"ref=176","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/00004714-198710000-00002","volume":"7","author":"Fawcett J.","year":"1987","unstructured":"Fawcett J.; Edwards J.H.; Kravitz H.M.; Jeffriess H.; Alprazolam: an antidepressant? Alprazolam, desipramine, and an alprazolam-desipramine combination in the treatment of adult depressed outpatients. J Clin Psychopharmacol 1987,7(5),295-310","journal-title":"J Clin Psychopharmacol"},{"key":"ref=177","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/0006-3223(95)00049-7","volume":"38","author":"Petty F.","year":"1995","unstructured":"Petty F.; Trivedi M.H.; Fulton M.; Rush A.J.; Benzodiazepines as antidepressants: does GABA play a role in depression? Biol Psychiatry 1995,38(9),578-591","journal-title":"Biol Psychiatry"},{"key":"ref=178","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000486696","volume":"87","author":"Benasi G.","year":"2018","unstructured":"Benasi G.; Guidi J.; Offidani E.; Balon R.; Rickels K.; Fava G.A.; Benzodiazepines as a monotherapy in depressive disorders: a systematic review. Psychother Psychosom 2018,87(2),65-74","journal-title":"Psychother Psychosom"},{"key":"ref=179","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.biopsych.2016.02.009","volume":"80","author":"Ren Z.","year":"2016","unstructured":"Ren Z.; Pribiag H.; Jefferson S.J.; Shorey M.; Fuchs T.; Stellwagen D.; Luscher B.; Bidirectional homeostatic regulation of a depression-related brain state by gamma-aminobutyric acidergic deficits and ketamine treatment. Biol Psychiatry 2016,80(6),457-468","journal-title":"Biol Psychiatry"},{"key":"ref=180","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.biopsych.2005.05.017","volume":"58","author":"Hasler G.","year":"2005","unstructured":"Hasler G.; Neumeister A.; van der Veen J.W.; Tumonis T.; Bain E.E.; Shen J.; Drevets W.C.; Charney D.S.; Normal prefrontal gamma-aminobutyric acid levels in remitted depressed subjects determined by proton magnetic resonance spectroscopy. Biol Psychiatry 2005,58(12),969-973","journal-title":"Biol Psychiatry"},{"key":"ref=181","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1126\/science.1234274","volume":"340","author":"Chiu C.Q.","year":"2013","unstructured":"Chiu C.Q.; Lur G.; Morse T.M.; Carnevale N.T.; Ellis- Davies G.C.; Higley M.J.; Compartmentalization of GABAergic inhibition by dendritic spines. Science 2013,340(6133),759-762","journal-title":"Science"},{"key":"ref=182","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.biopsych.2017.01.004","volume":"81","author":"Krystal J.H.","year":"2017","unstructured":"Krystal J.H.; Anticevic A.; Yang G.J.; Dragoi G.; Driesen N.R.; Wang X.J.; Murray J.D.; Impaired tuning of neural ensembles and the pathophysiology of schizophrenia: A translational and computational neuroscience perspective. Biol Psychiatry 2017,81(10),874-885","journal-title":"Biol Psychiatry"},{"key":"ref=183","doi-asserted-by":"publisher","first-page":"e47441","DOI":"10.1371\/journal.pone.0047441","volume":"7","author":"Shen Q.","year":"2012","unstructured":"Shen Q.; Fuchs T.; Sahir N.; Luscher B.; GABAergic control of critical developmental periods for anxiety- and depression-related behavior in mice. PLoS One 2012,7(10),e47441","journal-title":"PLoS One"},{"key":"ref=184","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3389\/fpsyt.2015.00068","volume":"6","author":"Lopizzo N.","year":"2015","unstructured":"Lopizzo N.; Bocchio Chiavetto L.; Cattane N.; Plazzotta G.; Tarazi F.I.; Pariante C.M.; Riva M.A.; Cattaneo A.; Gene-environment interaction in major depression: focus on experience-dependent biological systems. Front Psychiatry 2015,6,68","journal-title":"Front Psychiatry"},{"key":"ref=185","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.biopsych.2016.03.2101","volume":"80","author":"McKlveen J.M.","year":"2016","unstructured":"McKlveen J.M.; Morano R.L.; Fitzgerald M.; Zoubovsky S.; Cassella S.N.; Scheimann J.R.; Ghosal S.; Mahbod P.; Packard B.A.; Myers B.; Baccei M.L.; Herman J.P.; Chronic stress increases prefrontal inhibition: A mechanism for stress-induced prefrontal dysfunction. Biol Psychiatry 2016,80(10),754-764","journal-title":"Biol Psychiatry"},{"key":"ref=186","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1146\/annurev-publhealth-040617-014158","volume":"39","author":"Ramaswami R.","year":"2018","unstructured":"Ramaswami R.; Bayer R.; Galea S.; Precision medicine from a public health perspective. Annu Rev Public Health 2018,39,153-168","journal-title":"Annu Rev Public Health"},{"key":"ref=187","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/da.20262","volume":"24","author":"Kalueff A.V.","year":"2007","unstructured":"Kalueff A.V.; Nutt D.J.; Role of GABA in anxiety and depression. Depress Anxiety 2007,24(7),495-517","journal-title":"Depress Anxiety"},{"key":"ref=188","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s00213-009-1562-z","volume":"205","author":"Kumar S.","year":"2009","unstructured":"Kumar S.; Porcu P.; Werner D.F.; Matthews D.B.; Diaz-Granados J.L.; Helfand R.S.; Morrow A.L.; The role of GABA(A) receptors in the acute and chronic effects of ethanol: a decade of progress. Psychopharmacology (Berl) 2009,205(4),529-564","journal-title":"Psychopharmacology (Berl)"},{"key":"ref=189","doi-asserted-by":"publisher","first-page":"e655","DOI":"10.1038\/tp.2015.152","volume":"5","author":"Rivero O.","year":"2015","unstructured":"Rivero O.; Selten M.M.; Sich S.; Popp S.; Bacmeister L.; Amendola E.; Negwer M.; Schubert D.; Proft F.; Kiser D.; Schmitt A.G.; Gross C.; Kolk S.M.; Strekalova T.; van den Hove D.; Resink T.J.; Nadif Kasri N.; Lesch K.P.; Cadherin-13, a risk gene for ADHD and comorbid disorders, impacts GABAergic function in hippocampus and cognition. Transl Psychiatry 2015,5(10),e655","journal-title":"Transl Psychiatry"},{"key":"ref=190","doi-asserted-by":"publisher","first-page":"k5354","DOI":"10.1136\/bmj.k5354","volume":"363","author":"McLachlan G.","year":"2018","unstructured":"McLachlan G.; Treatment resistant depression: what are the options? BMJ 2018,363,k5354","journal-title":"BMJ"},{"key":"ref=191","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.neubiorev.2012.10.005","volume":"37","author":"Zorumski C.F.","year":"2013","unstructured":"Zorumski C.F.; Paul S.M.; Izumi Y.; Covey D.F.; Mennerick S.; Neurosteroids, stress and depression: Potential therapeutic opportunities. Neurosci Biobehav Rev 2013,37(1),109-122","journal-title":"Neurosci Biobehav Rev"},{"key":"ref=192","doi-asserted-by":"publisher","first-page":"FSO654","DOI":"10.2144\/fsoa-2020-0108","volume":"7","author":"Fasipe O.J.","year":"2020","unstructured":"Fasipe O.J.; Agede O.A.; Enikuomehin A.C.; Announcing the novel class of GABA-A receptor selective positive allosteric modulator antidepressants. Future Sci OA 2020,7(2),FSO654","journal-title":"Future Sci OA"},{"key":"ref=193","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/S0140-6736(18)31551-4","volume":"392","author":"Meltzer-Brody S.","year":"2018","unstructured":"Meltzer-Brody S.; Colquhoun H.; Riesenberg R.; Epperson C.N.; Deligiannidis K.M.; Rubinow D.R.; Li H.; Sankoh A.J.; Clemson C.; Schacterle A.; Jonas J.; Kanes S.; Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials. Lancet 2018,392(10152),1058-1070","journal-title":"Lancet"},{"key":"ref=194","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1177\/1060028019873320","volume":"54","author":"Powell J.G.","year":"2020","unstructured":"Powell J.G.; Garland S.; Preston K.; Piszczatoski C.; Brexanolone (Zulresso): finally, an FDA-approved treatment for postpartum depression. Ann Pharmacother 2020,54(2),157-163","journal-title":"Ann Pharmacother"},{"key":"ref=195","doi-asserted-by":"publisher","first-page":"7810","DOI":"10.1021\/acs.jmedchem.7b00846","volume":"60","author":"Martinez Botella G.","year":"2017","unstructured":"Martinez Botella G.; Salituro F.G.; Harrison B.L.; Beresis R.T.; Bai Z.; Blanco M.J.; Belfort G.M.; Dai J.; Loya C.M.; Ackley M.A.; Althaus A.L.; Grossman S.J.; Hoffmann E.; Doherty J.J.; Robichaud A.J.; Neuroactive steroids. 2. 3\u03b1-Hydroxy-3\u03b2-methyl-21-(4-cyano-1H-pyrazol-1\u2032-yl)-19-nor-5\u03b2-pregnan-20-one (SAGE-217): a clinical next generation neuroactive steroid positive allosteric modulator of the (\u03b3-aminobutyric acid)A receptor. J Med Chem 2017,60(18),7810-7819","journal-title":"J Med Chem"},{"key":"ref=196","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1056\/NEJMoa1815981","volume":"381","author":"Gunduz-Bruce H.","year":"2019","unstructured":"Gunduz-Bruce H.; Silber C.; Kaul I.; Rothschild A.J.; Riesenberg R.; Sankoh A.J.; Li H.; Lasser R.; Zorumski C.F.; Rubinow D.R.; Paul S.M.; Jonas J.; Doherty J.J.; Kanes S.J.; Trial of SAGE-217 in patients with major depressive disorder. N Engl J Med 2019,381(10),903-911","journal-title":"N Engl J Med"},{"key":"ref=197","doi-asserted-by":"publisher","first-page":"19m12887","DOI":"10.4088\/JCP.19m12887","volume":"81","author":"Dichtel L.E.","year":"2020","unstructured":"Dichtel L.E.; Nyer M.; Dording C.; Fisher L.B.; Cusin C.; Shapero B.G.; Pedrelli P.; Kimball A.S.; Rao E.M.; Mischouldon D.; Fava M.; Miller K.K.; Effects of open-label, adjunctive ganaxolone on persistent depression despite adequate antidepressant treatment in postmenopausal women: a pilot study. J Clin Psychiatry 2020,81(4),19m12887","journal-title":"J Clin Psychiatry"},{"key":"ref=198","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.coph.2017.07.009","volume":"35","author":"Alexander R.C.","year":"2017","unstructured":"Alexander R.C.; The potential efficacy of GABA antagonists in depression. Curr Opin Pharmacol 2017,35,101-104","journal-title":"Curr Opin Pharmacol"},{"key":"ref=199","doi-asserted-by":"publisher","first-page":"107494","DOI":"10.1016\/j.pharmthera.2020.107494","volume":"208","author":"Li Y.F.","year":"2020","unstructured":"Li Y.F.; A hypothesis of monoamine (5-HT) - Glutamate\/GABA long neural circuit: aiming for fast-onset antidepressant discovery. Pharmacol Ther 2020,208,107494","journal-title":"Pharmacol Ther"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867328666211115124149","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/197930\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867328666211115124149","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T16:02:54Z","timestamp":1691596974000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/197930\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":199,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867328666211115124149","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-06-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-21","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-30","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}